DE2059092C3 - Im Zuckerrest substituierte Convallatoxinderivate und Verfahren zu ihrer Herstellung - Google Patents
Im Zuckerrest substituierte Convallatoxinderivate und Verfahren zu ihrer HerstellungInfo
- Publication number
- DE2059092C3 DE2059092C3 DE19702059092 DE2059092A DE2059092C3 DE 2059092 C3 DE2059092 C3 DE 2059092C3 DE 19702059092 DE19702059092 DE 19702059092 DE 2059092 A DE2059092 A DE 2059092A DE 2059092 C3 DE2059092 C3 DE 2059092C3
- Authority
- DE
- Germany
- Prior art keywords
- convallatoxin
- preparation
- sugar residue
- derivatives substituted
- hours
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 238000000034 method Methods 0.000 title claims description 8
- 238000002360 preparation method Methods 0.000 title claims description 4
- HULMNSIAKWANQO-JQKSAQOKSA-N convallatoxin Chemical group O[C@@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@H]1O[C@@H]1C[C@@]2(O)CC[C@H]3[C@@]4(O)CC[C@H](C=5COC(=O)C=5)[C@@]4(C)CC[C@@H]3[C@@]2(C=O)CC1 HULMNSIAKWANQO-JQKSAQOKSA-N 0.000 title description 7
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 12
- OPHYOSQDKQYDCM-UHFFFAOYSA-N Convallatoxin Natural products CC1OC(OC2CCC3(C=O)C4CCC5(C)C(CCC5(O)C4CCC3(O)C2)C6=CCC(=O)O6)C(O)C(O)C1O OPHYOSQDKQYDCM-UHFFFAOYSA-N 0.000 description 10
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 10
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 9
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 8
- 150000001875 compounds Chemical class 0.000 description 7
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 6
- 125000002485 formyl group Chemical group [H]C(*)=O 0.000 description 6
- 238000004587 chromatography analysis Methods 0.000 description 5
- RTZKZFJDLAIYFH-UHFFFAOYSA-N ether Substances CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 5
- 239000002253 acid Substances 0.000 description 4
- 125000000217 alkyl group Chemical group 0.000 description 4
- 238000006243 chemical reaction Methods 0.000 description 4
- 230000007062 hydrolysis Effects 0.000 description 4
- 238000006460 hydrolysis reaction Methods 0.000 description 4
- OKKJLVBELUTLKV-UHFFFAOYSA-N methanol Natural products OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 4
- -1 methylene compound Chemical class 0.000 description 4
- 239000000843 powder Substances 0.000 description 4
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 3
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 3
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 3
- 125000004029 hydroxymethyl group Chemical group [H]OC([H])([H])* 0.000 description 3
- 230000008018 melting Effects 0.000 description 3
- 238000002844 melting Methods 0.000 description 3
- 239000000741 silica gel Substances 0.000 description 3
- 229910002027 silica gel Inorganic materials 0.000 description 3
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 3
- 235000017557 sodium bicarbonate Nutrition 0.000 description 3
- 238000003756 stirring Methods 0.000 description 3
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- UQEKVLJMBGSQGS-UHFFFAOYSA-N Desglucocheirotoxol Natural products OC1C(O)C(O)C(C)OC1OC1CC2(O)CCC3C4(O)CCC(C=5COC(=O)C=5)C4(C)CCC3C2(CO)CC1 UQEKVLJMBGSQGS-UHFFFAOYSA-N 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- 230000003177 cardiotonic effect Effects 0.000 description 2
- 239000006260 foam Substances 0.000 description 2
- 229910052500 inorganic mineral Inorganic materials 0.000 description 2
- 239000011707 mineral Substances 0.000 description 2
- 235000010755 mineral Nutrition 0.000 description 2
- 239000012299 nitrogen atmosphere Substances 0.000 description 2
- 239000003208 petroleum Substances 0.000 description 2
- 239000002904 solvent Substances 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 1
- WTFUTSCZYYCBAY-SXBRIOAWSA-N 6-[(E)-C-[[4-[2-(2,3-dihydro-1H-inden-2-ylamino)pyrimidin-5-yl]piperazin-1-yl]methyl]-N-hydroxycarbonimidoyl]-3H-1,3-benzoxazol-2-one Chemical compound C1C(CC2=CC=CC=C12)NC1=NC=C(C=N1)N1CCN(CC1)C/C(=N/O)/C1=CC2=C(NC(O2)=O)C=C1 WTFUTSCZYYCBAY-SXBRIOAWSA-N 0.000 description 1
- 241000282326 Felis catus Species 0.000 description 1
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 1
- 125000003172 aldehyde group Chemical group 0.000 description 1
- 238000003776 cleavage reaction Methods 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 238000002425 crystallisation Methods 0.000 description 1
- 230000008025 crystallization Effects 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 230000008030 elimination Effects 0.000 description 1
- 238000003379 elimination reaction Methods 0.000 description 1
- 230000008020 evaporation Effects 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- 238000001990 intravenous administration Methods 0.000 description 1
- 231100000636 lethal dose Toxicity 0.000 description 1
- 229910052987 metal hydride Inorganic materials 0.000 description 1
- 150000004681 metal hydrides Chemical class 0.000 description 1
- 238000012544 monitoring process Methods 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 239000012074 organic phase Substances 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 239000011541 reaction mixture Substances 0.000 description 1
- 230000035484 reaction time Effects 0.000 description 1
- 238000001226 reprecipitation Methods 0.000 description 1
- 230000007017 scission Effects 0.000 description 1
- 229910000033 sodium borohydride Inorganic materials 0.000 description 1
- 239000012279 sodium borohydride Substances 0.000 description 1
- 229910052938 sodium sulfate Inorganic materials 0.000 description 1
- 235000011152 sodium sulphate Nutrition 0.000 description 1
- 238000005476 soldering Methods 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J19/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 by a lactone ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J75/00—Processes for the preparation of steroids in general
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
Priority Applications (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19702059092 DE2059092C3 (de) | 1970-12-01 | 1970-12-01 | Im Zuckerrest substituierte Convallatoxinderivate und Verfahren zu ihrer Herstellung |
| CH1708471A CH565818A5 (enExample) | 1970-12-01 | 1971-11-24 | |
| NL7116195A NL160569C (nl) | 1970-12-01 | 1971-11-25 | Werkwijze voor de bereiding van convallatoxinederivaten en van preparaten die ze bevatten. |
| AT1020471A AT314093B (de) | 1970-12-01 | 1971-11-26 | Verfahren zur Herstellung von im Zuckerrest substituierten Convallatoxinderivaten |
| FR7142808A FR2116421A1 (en) | 1970-12-01 | 1971-11-30 | Convallatoxin derivs - oral cardiotonics |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19702059092 DE2059092C3 (de) | 1970-12-01 | 1970-12-01 | Im Zuckerrest substituierte Convallatoxinderivate und Verfahren zu ihrer Herstellung |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| DE2059092A1 DE2059092A1 (de) | 1972-07-13 |
| DE2059092B2 DE2059092B2 (de) | 1974-02-21 |
| DE2059092C3 true DE2059092C3 (de) | 1974-10-10 |
Family
ID=5789650
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE19702059092 Expired DE2059092C3 (de) | 1970-12-01 | 1970-12-01 | Im Zuckerrest substituierte Convallatoxinderivate und Verfahren zu ihrer Herstellung |
Country Status (5)
| Country | Link |
|---|---|
| AT (1) | AT314093B (enExample) |
| CH (1) | CH565818A5 (enExample) |
| DE (1) | DE2059092C3 (enExample) |
| FR (1) | FR2116421A1 (enExample) |
| NL (1) | NL160569C (enExample) |
-
1970
- 1970-12-01 DE DE19702059092 patent/DE2059092C3/de not_active Expired
-
1971
- 1971-11-24 CH CH1708471A patent/CH565818A5/xx not_active IP Right Cessation
- 1971-11-25 NL NL7116195A patent/NL160569C/xx not_active IP Right Cessation
- 1971-11-26 AT AT1020471A patent/AT314093B/de not_active IP Right Cessation
- 1971-11-30 FR FR7142808A patent/FR2116421A1/fr active Granted
Also Published As
| Publication number | Publication date |
|---|---|
| CH565818A5 (enExample) | 1975-08-29 |
| AT314093B (de) | 1974-03-25 |
| NL160569C (nl) | 1979-11-15 |
| FR2116421B1 (enExample) | 1976-07-02 |
| NL7116195A (enExample) | 1972-06-05 |
| DE2059092A1 (de) | 1972-07-13 |
| FR2116421A1 (en) | 1972-07-13 |
| NL160569B (nl) | 1979-06-15 |
| DE2059092B2 (de) | 1974-02-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE1568950A1 (de) | Steroid-[17alpha,16alpha-d]-oxazoline und Verfahren zu ihrer Herstellung | |
| DE2030402B2 (de) | 3 alpha-Hydroxy-21-hydroxy-5 alphapregnan-11,20-dion-21-ester und Verfahren zu ihrer Herstellung | |
| CH635594A5 (de) | Verfahren zur herstellung von neuen gona-4,9(10)-dienen. | |
| DE2059092C3 (de) | Im Zuckerrest substituierte Convallatoxinderivate und Verfahren zu ihrer Herstellung | |
| DE1568216C (de) | In 3,4 Stellung cyclische Äther tragende Cardenohd digitoxoside sowie Verfahren zu ihrer Herstellung | |
| AT205679B (de) | Verfahren zur Herstellung 3, 11, 17-substituierter Steroide | |
| DE1768140C (de) | Verfahren zur Herstellung von Herzglykosidderivaten und Arzneimittel | |
| DE2364741C3 (de) | Selen 75-Derivate von Steroiden | |
| DE2419207C3 (de) | Verfahren zur Herstellung von 3-Hemisulfat-17alpha hydroxy-steroiden | |
| AT217646B (de) | Verfahren zur Herstellung von 18- und bzw. oder 21-Äthern und Thioäthern des Aldosterons | |
| DE1768142C (de) | Verfahren zur Herstellung von Herzglykosidderivaten und Arzneimittel | |
| DE1002347C2 (de) | Verfahren zur Herstellung von in 4(5)-Stellung ungesaettigten 2-Jodsteroid-3-ketonen bzw. Steroid-3-ketonen | |
| DE1793685C3 (de) | Helveticosidderivate | |
| DE940463C (de) | Verfahren zur Herstellung von 4-Pregnen-11ª‰, 17ª‡, 21-triol-3, 20-dion (Kendalls Verbindung F) | |
| AT270882B (de) | Verfahren zur Herstellung von neuen, leicht resorbierbaren Proscillaridinketalen | |
| DE1593064A1 (de) | Verfahren zur Herstellung von 16-Methyl-4-pregnen-3-ss-o1-20-onen | |
| DE1568216B (de) | In 3, 4-Stellung cyclische Äther tragende Cardenohd digitoxoside sowie Verfahren zu ihrer Herstellung | |
| DE1768140B (de) | Verfahren zur Herstellung von Herzglykosidderivaten und Arzneimittel | |
| DE1768140A1 (de) | Herzglykosidderivate des Strophanthidintyps,Verfahren zu ihrer Herstellung und ihre Verwendung zur Herstellung von Arzneipraeparaten | |
| DE1177147B (de) | Verfahren zur Herstellung von 3-Enolaethern von 6-Formyl-3-oxo-?-steroiden | |
| CH551960A (de) | Verfahren zur herstellung von neuen 21-pregnen-21-aldehyd-acetalen. | |
| DE1965963B2 (de) | Steroidoxazolidine und steroidoxazolidinoxazine und verfahren zu ihrer herstellung | |
| DE1768142A1 (de) | Herzglykosidderivate des Strophantidintyps,Verfahren zu ihrer Herstellung und ihre Verwendung zur Herstellung von Arzneipraeparaten | |
| DE1021367B (de) | Verfahren zur Herstellung von neuen Halogenpregnenen | |
| DE1043331B (de) | Verfahren zur Herstellung von in 8-Stellung ungesaettigten 11-Ketosteroiden der Ergostanreihe |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C3 | Grant after two publication steps (3rd publication) | ||
| E77 | Valid patent as to the heymanns-index 1977 | ||
| 8339 | Ceased/non-payment of the annual fee |